(1 - 34 von 44
)
Aptamer Group trades on AIM market of the London Stock ...
www.yorkpress.co.uk
— From left: Arron Tolley, CEO of Aptamer Group, with co-founder Dr David Bunka, Harriet Flynn, Joe Reed and Banushan Balansethupathy at The ... › news
Guardian: UK biotech firm Aptamer to float valued at £80.7m | Biotechnology...
York-based company makes synthetic antibodies for … firms including AstraZeneca
Monday newspaper round-up: Aptamer, household savings, hospitality
www.sharecast.com
— , an early school leaver who later completed a doctorate in biophysics and molecular biology, and Dr David Bunka, a geneticist. › news
Aptamer IPO: How to buy shares of this biotechnology firm on AIM?
kalkinemedia.com
Highlights
UK biotechnology firm, Aptamer, is all set to make a debut on LSE’s AIM sub-segment.
Over the last four years, the com...
sortiert nach Relevanz / Datum